161 related articles for article (PubMed ID: 37607892)
1. Developmental age and fatty acid amide hydrolase genetic variation converge to mediate fear regulation in female mice.
Gerhard DM; Tse N; Lee FS; Meyer HC
Dev Psychobiol; 2023 Sep; 65(6):e22409. PubMed ID: 37607892
[TBL] [Abstract][Full Text] [Related]
2. Kaempferol Facilitated Extinction Learning in Contextual Fear Conditioned Rats via Inhibition of Fatty-Acid Amide Hydrolase.
Ahmad H; Rauf K; Zada W; McCarthy M; Abbas G; Anwar F; Shah AJ
Molecules; 2020 Oct; 25(20):. PubMed ID: 33066366
[No Abstract] [Full Text] [Related]
3. Upregulation of Anandamide Hydrolysis in the Basolateral Complex of Amygdala Reduces Fear Memory Expression and Indices of Stress and Anxiety.
Morena M; Aukema RJ; Leitl KD; Rashid AJ; Vecchiarelli HA; Josselyn SA; Hill MN
J Neurosci; 2019 Feb; 39(7):1275-1292. PubMed ID: 30573646
[TBL] [Abstract][Full Text] [Related]
4. Elevated Anandamide, Enhanced Recall of Fear Extinction, and Attenuated Stress Responses Following Inhibition of Fatty Acid Amide Hydrolase: A Randomized, Controlled Experimental Medicine Trial.
Mayo LM; Asratian A; Lindé J; Morena M; Haataja R; Hammar V; Augier G; Hill MN; Heilig M
Biol Psychiatry; 2020 Mar; 87(6):538-547. PubMed ID: 31590924
[TBL] [Abstract][Full Text] [Related]
5. The influence of FAAH genetic variation on physiological, cognitive, and neural signatures of fear acquisition and extinction learning in women with PTSD.
Crombie KM; Privratsky AA; Schomaker CM; Heilicher M; Ross MC; Sartin-Tarm A; Sellnow K; Binder EB; Andrew James G; Cisler JM
Neuroimage Clin; 2022; 33():102922. PubMed ID: 34952353
[TBL] [Abstract][Full Text] [Related]
6. FAAH polymorphism (rs324420) modulates extinction recall in healthy humans: an fMRI study.
Spohrs J; Ulrich M; Grön G; Plener PL; Abler B
Eur Arch Psychiatry Clin Neurosci; 2022 Dec; 272(8):1495-1504. PubMed ID: 34893921
[TBL] [Abstract][Full Text] [Related]
7. Fear extinction learning and anandamide: an fMRI study in healthy humans.
Spohrs J; Ulrich M; Grön G; Prost M; Plener PL; Fegert JM; Bindila L; Abler B
Transl Psychiatry; 2021 Mar; 11(1):161. PubMed ID: 33723207
[TBL] [Abstract][Full Text] [Related]
8. Protective effects of elevated anandamide on stress and fear-related behaviors: translational evidence from humans and mice.
Mayo LM; Asratian A; Lindé J; Holm L; Nätt D; Augier G; Stensson N; Vecchiarelli HA; Balsevich G; Aukema RJ; Ghafouri B; Spagnolo PA; Lee FS; Hill MN; Heilig M
Mol Psychiatry; 2020 May; 25(5):993-1005. PubMed ID: 30120421
[TBL] [Abstract][Full Text] [Related]
9. A common genetic variant in fatty acid amide hydrolase is linked to alterations in fear extinction neural circuitry in a racially diverse, nonclinical sample of adults.
Zabik NL; Iadipaolo AS; Marusak HA; Peters C; Burghardt K; Rabinak CA
J Neurosci Res; 2022 Mar; 100(3):744-761. PubMed ID: 34051704
[TBL] [Abstract][Full Text] [Related]
10. Effects of endocannabinoid and endovanilloid systems on aversive memory extinction.
Laricchiuta D; Centonze D; Petrosini L
Behav Brain Res; 2013 Nov; 256():101-7. PubMed ID: 23948212
[TBL] [Abstract][Full Text] [Related]
11. Endocannabinoid modulating drugs improve anxiety but not the expression of conditioned fear in a rodent model of post-traumatic stress disorder.
Vimalanathan A; Gidyk DC; Diwan M; Gouveia FV; Lipsman N; Giacobbe P; Nobrega JN; Hamani C
Neuropharmacology; 2020 Apr; 166():107965. PubMed ID: 31962287
[TBL] [Abstract][Full Text] [Related]
12. Involvement of Endocannabinoids in Alcohol "Binge" Drinking: Studies of Mice with Human Fatty Acid Amide Hydrolase Genetic Variation and After CB1 Receptor Antagonists.
Zhou Y; Huang T; Lee F; Kreek MJ
Alcohol Clin Exp Res; 2016 Mar; 40(3):467-73. PubMed ID: 26857901
[TBL] [Abstract][Full Text] [Related]
13. Increased Contextual Fear Conditioning in iNOS Knockout Mice: Additional Evidence for the Involvement of Nitric Oxide in Stress-Related Disorders and Contribution of the Endocannabinoid System.
Lisboa SF; Gomes FV; Silva AL; Uliana DL; Camargo LH; Guimarães FS; Cunha FQ; Joca SR; Resstel LB
Int J Neuropsychopharmacol; 2015 Jan; 18(8):. PubMed ID: 25618404
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of fatty-acid amide hydrolase accelerates acquisition and extinction rates in a spatial memory task.
Varvel SA; Wise LE; Niyuhire F; Cravatt BF; Lichtman AH
Neuropsychopharmacology; 2007 May; 32(5):1032-41. PubMed ID: 17047668
[TBL] [Abstract][Full Text] [Related]
15. Cannabinoid polymorphisms interact with plasma endocannabinoid levels to predict fear extinction learning.
Ney LJ; Matthews A; Hsu CK; Zuj DV; Nicholson E; Steward T; Nichols D; Graham B; Harrison B; Bruno R; Felmingham K
Depress Anxiety; 2021 Oct; 38(10):1087-1099. PubMed ID: 34151472
[TBL] [Abstract][Full Text] [Related]
16. The role of the cannabinoid system in fear memory and extinction in male and female mice.
Mizuno I; Matsuda S; Tohyama S; Mizutani A
Psychoneuroendocrinology; 2022 Apr; 138():105688. PubMed ID: 35176534
[TBL] [Abstract][Full Text] [Related]
17. The endocannabinoid system in the amygdala and modulation of fear.
Gunduz-Cinar O
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Mar; 105():110116. PubMed ID: 32976951
[TBL] [Abstract][Full Text] [Related]
18. FAAH genetic variation enhances fronto-amygdala function in mouse and human.
Dincheva I; Drysdale AT; Hartley CA; Johnson DC; Jing D; King EC; Ra S; Gray JM; Yang R; DeGruccio AM; Huang C; Cravatt BF; Glatt CE; Hill MN; Casey BJ; Lee FS
Nat Commun; 2015 Mar; 6():6395. PubMed ID: 25731744
[TBL] [Abstract][Full Text] [Related]
19. Individual differences in frontolimbic circuitry and anxiety emerge with adolescent changes in endocannabinoid signaling across species.
Gee DG; Fetcho RN; Jing D; Li A; Glatt CE; Drysdale AT; Cohen AO; Dellarco DV; Yang RR; Dale AM; Jernigan TL; Lee FS; Casey BJ;
Proc Natl Acad Sci U S A; 2016 Apr; 113(16):4500-5. PubMed ID: 27001846
[TBL] [Abstract][Full Text] [Related]
20. Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors.
Moreira FA; Kaiser N; Monory K; Lutz B
Neuropharmacology; 2008 Jan; 54(1):141-50. PubMed ID: 17709120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
